Telemedicine in the Management of Type 2 Diabetes Mellitus.

Source: Wang, G., et al. 2017 - Pubmed ID: 28104096

Setting: China, Hospital

Study design:


Follow up: 6 months

Patient group:

Sample size:

Total: 212 (178)

IG: 106 ( 93)

CG: 106 ( 85)

Inclusion criteria:

– Type 2 diabetes.

– HbA1c 7-10.0%

Type of technology:

Home monitoring equipment
– Glucometer

– Datatransfer
– Messaging

– messaging


Intervention: Patients upload data to website 2 times a day, 2-3 days/week. Medical team log on to the website every 2 week to analyse data and to deliver advice to the patient leaving messages on the website or via telephone.  

Duration: 6 months

Add on: NA

Control group: Usual care

Clinical effect/ Patient safety:

Clinical effect:

– HbA1c ↓

– Plasma glucose ↓

Patient safety:

No severe hypoglycemic event was reported during the study.

Patient experiences/ Staff experiences:

Patient experiences:

Satisfaction score: 3.3-3.9/5.

80% patients in IG had been compliant with blood glucose monitoring 2-3 days/week, compliance rate was 72%.

Staff experiences: NA

Costs and organization:

Home monitoring equipment

– Blood glucose monitor

Staff resources

– Development of website


Staff resources

– data monitoring and messaging



Health care utilization:


Scroll to Top


“↑”: Statistically significant increase

“↓”: Statistically significant decrease

“→”: Statistically insignificant (no difference)